Literature DB >> 15207959

Schizophrenia.

Kim T Mueser1, Susan R McGurk.   

Abstract

Schizophrenia is a mental illness that is among the world's top ten causes of long-term disability. The symptoms of schizophrenia include psychosis, apathy and withdrawal, and cognitive impairment, which lead to problems in social and occupational functioning, and self-care. About 1% of the population is affected by schizophrenia, with similar rates across different countries, cultural groups, and sexes. The illness tends to develop between the ages of 16 and 30 years, and mostly persists throughout the patient's lifetime. The cause of schizophrenia is unknown, but evidence suggests that genetic factors, early environmental influences (eg, obstetric complications), and social factors (eg, poverty) contribute. No biological alterations are pathognomonic of schizophrenia, although several pathophysiological differences exist in a wide range of brain structures. Antipsychotic medications are the mainstay for managing schizophrenia. A range of psychosocial treatments are also helpful, including family intervention, supported employment, cognitive-behaviour therapy for psychosis, social skills training, teaching illness self-management skills, assertive community treatment, and integrated treatment for co-occurring substance misuse.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207959     DOI: 10.1016/S0140-6736(04)16458-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  229 in total

1.  Injury risk and severity in a sample of Maryland residents with serious mental illness.

Authors:  Emma E McGinty; Susan P Baker; Donald M Steinwachs; Gail Daumit
Journal:  Inj Prev       Date:  2012-06-02       Impact factor: 2.399

2.  Association of PDE4B polymorphisms and schizophrenia in Northwestern Han Chinese.

Authors:  Fanglin Guan; Chen Zhang; Shuguang Wei; Hongbo Zhang; Xiaomin Gong; Jiali Feng; Chengge Gao; Rong Su; Huanming Yang; Shengbin Li
Journal:  Hum Genet       Date:  2011-12-11       Impact factor: 4.132

Review 3.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

4.  Culture, stress and recovery from schizophrenia: lessons from the field for global mental health.

Authors:  Neely Laurenzo Myers
Journal:  Cult Med Psychiatry       Date:  2010-09

Review 5.  Cognitive behavioural therapy (brief versus standard duration) for schizophrenia.

Authors:  Farooq Naeem; Saeed Farooq; David Kingdon
Journal:  Cochrane Database Syst Rev       Date:  2015-10-21

6.  An innovative model to coordinate healthcare and social services for people with serious mental illness: A mixed-methods case study of Maryland's Medicaid health home program.

Authors:  Emma E McGinty; Alene Kennedy-Hendricks; Sarah Linden; Seema Choksy; Elizabeth Stone; Gail L Daumit
Journal:  Gen Hosp Psychiatry       Date:  2017-12-16       Impact factor: 3.238

7.  DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics.

Authors:  Bruno R Souza; Bernardo S Motta; Daniela V F Rosa; Karen C L Torres; Adalberto A Castro; Clarissa M Comim; André M Sampaio; Fabrício F Lima; Andreas Jeromin; João Quevedo; Marco A Romano-Silva
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

8.  Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China.

Authors:  Mao-Sheng Ran; Xue Weng; Cecilia Lai-Wan Chan; Eric Yu-Hai Chen; Cui-Ping Tang; Fu-Rong Lin; Wen-Jun Mao; Shi-Hui Hu; Yue-Qin Huang; Meng-Ze Xiang
Journal:  Br J Psychiatry       Date:  2015-09-17       Impact factor: 9.319

9.  News media framing of serious mental illness and gun violence in the United States, 1997-2012.

Authors:  Emma E McGinty; Daniel W Webster; Marian Jarlenski; Colleen L Barry
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

10.  Psychological conditions in adults with diabetes.

Authors:  Mary de Groot; Sherita Hill Golden; Julie Wagner
Journal:  Am Psychol       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.